Stockscreener 앱 받기
11.49
0.70%
0.08
시간 외 거래:
11.49
전일 마감가:
$11.41
열려 있는:
$11.58
하루 거래량:
9,117
Relative Volume:
0.34
시가총액:
$22.60M
수익:
-
순이익/손실:
$-4.85M
주가수익비율:
-37.06
EPS:
-0.31
순현금흐름:
$-3.95M
1주 성능:
+1.77%
1개월 성능:
+11.01%
6개월 성능:
-40.59%
1년 성능:
+77.40%
1일 변동 폭
$11.25
$11.58
1주일 범위
$10.45
$11.98
52주 변동 폭
$5.70
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
명칭
Cadrenal Therapeutics Inc
전화
904-300-0701
주소
822 A1A NORTH, PONTE VEDRA
CVKD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
11.49 | 22.44M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-18 | 개시 | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc 주식(CVKD)의 최신 뉴스
Why EFOI stock attracts strong analyst attentionSmart Money Signals - Metal.it
What drives Cadrenal Therapeutics Inc. stock priceJaw-dropping returns - PrintWeekIndia
P 500Consistent high-performance stocks - jammulinksnews.com
Cadrenal Therapeutics Inc. Stock Analysis and ForecastExceptional market performance - Autocar Professional
Is Cadrenal Therapeutics Inc. a good long term investmentHigh-yield market plays - jammulinksnews.com
Outlook Therapeutics Inc. Stock Analysis and ForecastExplosive market performance - jammulinksnews.com
What analysts say about Cadrenal Therapeutics Inc. stockConsistently outstanding ROI - jammulinksnews.com
Monetizing Your Website through AdSenseSolid Return Trade Selections - Newser
(CVKD) Technical Pivots with Risk Controls - news.stocktradersdaily.com
What analysts say about TLSA stockOutstanding risk-reward balance - PrintWeekIndia
Cadrenal Therapeutics Director Resignation Announced - The Globe and Mail
Future of HOHOHO V2.0(santa floki v2) ExplainedEarly Breakout Tracker - Newser
Cadrenal Therapeutics director resigns; annual meeting set for September - Investing.com Australia
Candel Therapeutics (CADL) Shares Soar 9.60% - AInvest
What makes Cadrenal Therapeutics Inc. stock price move sharplyFree Capital Allocation Plans - Newser
How Cadrenal Therapeutics Inc. stock performs during market volatilityRisk Adjusted Stock Signals - Newser
Why Cadrenal Therapeutics Inc. stock attracts strong analyst attention10x Return With Managed Risk - Newser
Why Restaurant Brands International Inc. stock attracts strong analyst attentionFree Access to Community - Newser
(CVKD) Proactive Strategies - news.stocktradersdaily.com
Cadrenal Therapeutics (NASDAQ:CVKD) Trading 2.3% Higher – Here’s What Happened - Defense World
Why Did Cadrenal Therapeutics Soar 11.78%? - AInvest
(CVKD) Long Term Investment Analysis - news.stocktradersdaily.com
Pre-market Movers: XCUR, KLTO, INMB, SERA... - RTTNews
Cadrenal Therapeutics (NASDAQ:CVKD) Shares Down 0.1% – Here’s What Happened - Defense World
Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients - BioSpace
Cadrenal Therapeutics Inc (CVKD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.97%
0.22%
자본화:
|
볼륨(24시간):